Tussmuco 600 mg Effervescent tablets
PDF Leaflet Revision Date: 25 November 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Mucolytic for acute respiratory conditions.
Dosage (summary)
Adults: 1/2 tablet twice daily or 1 tablet once daily.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not established for safety in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Antitussives
- Tetracycline (except doxycycline)
- Glyceryl trinitrate
- ACE inhibitors
Contraindications
- Hypersensitivity to acetylcysteine
- Active peptic ulceration
- Pregnancy
Common side effects
- Nausea
- Vomiting
- Headache
- Bronchospasm
- Skin reactions
Counselling Points
- Dissolve tablet fully before intake
- Do not exceed 14 days without medical advice
- Monitor for allergic reactions
Serious warnings
- Severe skin reactions
- Risk of choking if not fully dissolved
Important Disclaimer
The Tussmuco 600 mg Effervescent tablets professional information leaflet below is the property of Pharmacare Ltd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
